Back Donate
Donate
Default image for pages

Gaul C, Kraya T, Holle D, Benkel-Herrenbruck I, Schara U, Ebinger F. “Migraine Variants and Unusual Types of Migraine in Childhood.” Schmerz (German) 25, no. 2 (April 2011): 148-156.

Kors E, VanMolkot K, Haan J, Kheradmand K, Stroink H, Laan L, Gill D, Pascual J, van den Maagdenberg A, Frants R. “Alternating Hemiplegia of Childhood: No Mutations in the Second Familial Hemiplegic Migraine Gene ATP1A2.” Neuropediatrics 35, no. 5 (October 2004): 293-296.

Lagman-Bartolome AM, Lay C. “Pediatric Migraine Variants: A Review of Epidemiology, Diagnosis, Treatment, and Outcome.” Curr Neurol Neurosci Rep. (April 24, 2015).

Kros L, Lykke-Hartmann K, Khodakhah K. “Increased Susceptibility to Cortical Spreading Depression and Epileptiform Activity in a Mouse Model for FHM2.” Scientific Reports. 2018; 8:16959. Fulltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240030/pdf/41598_2018_Article_35285.pdf

Lance JW. “Is Alternating Hemiplegia of Childhood (AHC) A Variant of Migraine?” Cephalalgia 20. no. 8 (October 2000): 685.

Lebas A, Guyant-Marechal L, Hannequin D, Riant F. “Severe Attacks of Familial Hemiplegic Migraine, Childhood Epilepsy and ATP1A2 Mutation.” Cephalalgia 28 (2008): 774-777.

Mohamed BP, Goadsby J, Prabhakar P. “Safety and Efficacy of Flunarizine in Childhood Migraine: 11 Years’ Experience, with Emphasis on its Effect in Hemiplegic Migraine.” Developmental Medicine & Child Neurology (January 23, 2012).

Pledger GW. “Flunarizine for Treatment of Partial Seizures: Results of a Concentration-Controlled Trial.” Neurology 44, no.10 (1994): 1830-1836.

Yang X, Gao H, Zhang J, Xu X, Liu X, Wu X, Wei L, Zhang Y. “ATP1A3 Mutations and Genotype-Phenotype Correlation of Alternating Hemiplegia of Childhood in Chinese Patients.” PLos ONE 9, no. 5 (May 2014).

Sasaki M, Ishii A, Saito Y, Morisada N, et al. “Genotype-Phenotype Correlations in Alternating Hemiplegia of Childhood.” Neurology (January 15, 2014).